Orpea SA (EMEIS) AI Stock Analysis

• Market Cap: €2.29B
• Dividend Yield: N/A
• Average Volume (3M): 477.80K
• Price to Earnings (P/E): <0.1
• Beta (1Y): 4.34
• Revenue Growth: 8.43%
• EPS Growth: -102.06%
• Country: FR
• Employees: 51,071
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -0.96
• Shares Outstanding: 161,440,050
• 10 Day Avg. Volume: 310,657
• 30 Day Avg. Volume: 477,798
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €9.00
• Price Target Upside: -30.77% Downside
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 1

• Rating: 51 Neutral
• Price Target: €13.50 ▲(3.85% Upside)

Orpea SA's overall stock score is primarily driven by financial performance concerns, including high leverage and profitability challenges. While technical analysis suggests potential short-term bullish momentum, the valuation metrics raise caution due to negative earnings. The absence of earnings call and corporate event data limits the overall assessment.

Orpea SA Business Overview & Revenue Model

Company Description

Orpea SA is a leading European provider of long-term care services, specializing in the management of nursing homes, rehabilitation centers, and assisted living facilities. The company operates across several countries, offering a range of services designed to support elderly individuals and those requiring medical assistance. Orpea's core offerings include residential care, post-acute care, and home care services, focusing on enhancing the quality of life for its residents through comprehensive healthcare and support.

How the Company Makes Money

Orpea SA primarily generates revenue through the provision of care services in its nursing homes and rehabilitation facilities. Key revenue streams include government reimbursements, private payments from residents, and health insurance reimbursements. The company benefits from partnerships with local governments and health authorities, which provide funding and subsidies for care services. Additionally, Orpea may earn income from ancillary services such as physiotherapy, occupational therapy, and other specialized medical services offered to residents. The company's strategic expansion into new markets and continuous investment in facility enhancements also contribute to its overall earnings.

Orpea SA Financial Statement Overview

Summary

Orpea SA's financial performance is concerning with negative EBIT and net income indicating operational challenges. High debt levels and negative stockholder equity further highlight financial distress, despite positive operating cash flow.

Income Statement

Orpea SA's revenue has shown a steady growth trend with a notable increase from 2020 to 2024. However, profitability metrics are concerning. Both EBIT and Net Income are negative in 2024, indicating operational challenges and lack of profitability. The gross profit margin has improved significantly from previous years, suggesting some operational efficiency gains, but the overall financial health is undermined by persistent losses.

Balance Sheet

The company has a high debt-to-equity ratio due to substantial total debt which has remained high over the years. While the equity ratio is low, indicating high leverage, the company's stockholder equity has been declining, posing a risk to financial stability. Negative stockholders' equity in recent years highlights financial distress.

Cash Flow

Orpea SA has managed to maintain positive operating cash flow, which is a positive sign of cash-generating capability. The free cash flow has shown growth, but the free cash flow to net income ratio indicates challenges, as net income remains negative. The operating cash flow to net income ratio is strong due to the negative net income, which reflects operational cash flow resilience despite profitability issues.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.64B	5.20B	4.68B	4.30B	3.92B
Gross Profit	4.51B	655.93M	713.73M	922.68M	963.25M
EBITDA	731.55M	2.80B	-3.45B	646.07M	637.64M
Net Income	-412.06M	1.35B	-4.03B	65.19M	160.05M
Balance Sheet
Total Assets	13.41B	13.91B	14.49B	17.07B	16.97B
Cash, Cash Equivalents and Short-Term Investments	518.72M	692.95M	902.99M	957.70M	894.13M
Total Debt	8.86B	9.16B	13.38B	12.25B	10.51B
Total Liabilities	11.69B	12.02B	16.00B	14.74B	13.48B
Stockholders Equity	1.72B	1.89B	-1.50B	2.32B	3.50B
Cash Flow
Free Cash Flow	328.61M	216.90M	244.74M	331.85M	283.29M
Operating Cash Flow	472.05M	366.14M	409.73M	753.75M	777.73M
Investing Cash Flow	-140.43M	-318.17M	-657.49M	-1.41B	-1.01B
Financing Cash Flow	-458.08M	-259.44M	151.81M	718.30M	285.80M

Orpea SA Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 13.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:EMEIS, the sentiment is Neutral. The current price of 13 is below the 20-day moving average (MA) of 13.56, above the 50-day MA of 12.19, and above the 200-day MA of 9.53, indicating a neutral trend. The MACD of 0.60 indicates Positive momentum. The RSI at 48.22 is Neutral, neither overbought nor oversold. The STOCH value of 50.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:EMEIS.

Orpea SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.81B	-0.15	-40.08%	2.29%	21.29%	-1.80%
EMEIS	51 Neutral	€2.29B	0.02	-22.82%	―	8.43%	-102.06%
0OPS	―	€1.65B	―	-1.70%	―	―	―
0OR2	―	€326.15M	14.62	7.12%	4.15%	―	―
0OD6	―	€1.09B	―	-6.74%	―	―	―